Clinical Trials Browser

Interventional × Neoplasms, Experimental × pembrolizumab × Clear all

NCT05296772 2023-09-06

Phase 1 First-in-human Study of JS014

Phase 1 Unknown

Lymphoma, Neoplasms, Neoplasms, Experimental